FDA Gives 510(k) Clearance to Respiratory Viral Panel Test for Rapid RSV, COVID-19 Detection
The approved assay can differentiate between infection of COVID-19, influenza, or respiratory syncytial virus, minimizing the need for multiple tests or physician visits.